FLORHAM PARK, N.J., Nov. 20, 2018 (GLOBE NEWSWIRE) -- Hisamitsu America, a division of Hisamitsu Pharmaceutical Co., Inc., and the marketers of the Salonpas® line of pain relieving products, announce the completion of a highly successful satellite media tour featuring Dr. Bob Arnot,  former Chief Medical Correspondent for NBC and CBS News and Jeffrey Gudin, MD, Director of the Pain Management and Wellness Center in Englewood, NJ, which identified topical analgesics as a preferred method to relieve pain while reducing reliance on opioids and Rx oral NSAIDs.  The broadcast campaign resulted in over 500 airings with a nationwide audience of over 15 million viewers.

On the heels of this successful ‘topical first’ broadcast campaign, Hisamitsu America is positioning the Salonpas® Pain Relieving Patch as an ideal gift this holiday season in a national digital billboard campaign.  From November 26th to December 23rd 2018, over 820 digital billboards across the country will be highlighting the Salonpas® Pain Relieving Patch as the ideal stocking stuffer to alleviate muscle, joint and back pain.  In New York City, a holiday Salonpas® billboard at 1500 Broadway will be showcasing the creative through January 2019.

“During the hustle and bustle of the holiday season, many people suffer from more aches and pains than usual and the Salonpas Pain Relieving Patch can help keep people feeling their best,” said John Incledon, President & CEO, Hisamitsu America.  “The Salonpas® Pain Relieving Patch includes three powerful pain fighters that work at the site of pain and provide safe, effective, lasting relief for backache, sore shoulders, stiff necks and joint pain. The affordable price and convenient-sized patches make it a fantastic stocking stuffer idea for a friend, family member, or coworker.”

About Hisamitsu America:
Hisamitsu America is the US division of Hisamitsu Pharmaceutical Co., Inc., founded in 1847, which has specialized in transdermal drug delivery system technology since the introduction of its Salonpas line of patches in 1934. The SALONPAS® product line, which gained early acceptance in Asia and now sells in over 30 countries, has pioneered the development of transdermal patches to relieve everyday aches and pains. Today, the Salonpas Pain Relief Patch Large is the first and only FDA-approved pain reliever labeled to relieve mild to tougher, moderate pain. For more information, visit www.salonpas.us.

Media Contact:  Nancy Thompson, Vorticom, Inc. 212.532.2208 (o), 917.371.4053 (m); nancyt@vorticom.com

Photos accompanying this announcement are available at

http://www.globenewswire.com/NewsRoom/AttachmentNg/95a5d990-ba51-4b86-8571-b77b0b375ca2

http://www.globenewswire.com/NewsRoom/AttachmentNg/fa963fa4-103c-4e80-a7b2-36835c298502